Fact CheckerSign in

NCT06137196Recruiting

Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia

Study on Risk Identification Factors for Lung Function Impairment in AIDS Patients Recovered From Severe Pneumonia

Source: ClinicalTrials.gov · Last updated 18 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Screening for risk factors related to lung function impairment in patients who have recovered from AIDS with severe pneumonia, to provide clinical evidence for early identification and intervention of lung function damage in this population.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
13 Nov 2023
Start date
1 Nov 2023
Primary completion date
1 Nov 2026
Lead sponsor
Guangzhou 8th People's Hospital
Diseases
HIV
NCT number
NCT06137196

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 Nov 2023 to the primary completion date, 1 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent central nervous system lesions, severe liver disease, or cirrhosis;
  • Concurrent AIDS-related or non-related tumors;
  • Alcohol abuse or drug use;

Other illness

  • Presence of serious underlying diseases such as heart, lung, liver, kidney, etc.;
  • The researcher believes that the overall condition of the subject affects the evaluation and completion of the trial

Other

  • Women who are pregnant or breastfeeding;

Who the study is looking for

  • Confirmed HIV infection;
  • Progression to the AIDS stage: CD4+ count \<200 cells/µL and/or occurrence of opportunistic infections associated with AIDS;
  • Age between 18 to 65 years;
  • Meet the diagnostic criteria for severe pneumonia, with reference to the 2021 treatment guidelines for community-acquired pneumonia developed by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA).

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Guangzhou Eighth People's Hospital, Guangzhou Medical University
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.